Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No one on the platform currently holds ONCR.
No tracked institution reports a position in ONCR as of their last filing.
No one on the platform has traded ONCR yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Beat consensus in 4 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2023-08-03 | $-0.61 | $-0.74 | -21.3% |
| 2023-05-22 | $-0.70 | $-1.18 | -68.6% |
| 2023-03-24 | $-0.78 | $-0.81 | -3.8% |
| 2022-11-02 | $-0.77 | $-0.76 | +1.3% |
| 2022-08-04 | $-0.74 | $-0.74 | +0.0% |
| 2022-05-04 | $-0.78 | $-0.69 | +11.5% |
| 2022-03-09 | $-0.71 | $-0.77 | -8.5% |
| 2021-11-03 | $-0.65 | $-0.65 | +0.0% |
| — |
| GRTSGritstone bio, Inc. | $0.03 | -31.78% | $4M | — |
| IDRAIdera Pharmaceuticals, Inc. | $0.42 | -23.04% | $0 | — |
Source: Financial Modeling Prep · peers by sector/industry
$ONCR ONCORUS, Inc. (NASDAQ:ONCR): Transforming Cancer Treatment with Innovative Self-Amplifying RNA Immunotherapies https://beyondspx.com/article/oncorus-inc-nasdaq-oncr-transforming-cancer-treatment-with-innovative-self-amplifying-rna-immunotherapies
View on StockTwits ↗$ONCR ONCORUS, Inc. (NASDAQ:ONCR): Transforming Cancer Treatment with Innovative Self-Amplifying RNA Immunotherapies http://beyondspx.com/2024/08/05/oncorus-inc-nasdaqoncr-transforming-cancer-treatment-with-innovative-self-amplifying-rna-immunotherapies/
View on StockTwits ↗
$FNCH like $ONCR on last nasdaq trading Day? Went from 0.08 to 0.33 on last day
View on StockTwits ↗
$ONCR I use fidelity.. and do not see dividends yet. Anyone else? With any broker?? You received dividends?
View on StockTwits ↗
@Gar_una I don't think it is corrupt at all. Most biotech companies spend everything and go negative before calling it quits. $ONCR executives and board had the guts to call it quits while there was still something left. I give them kudos for that. Biotech research companies are a gamble. Some hit it big. Most fail. Running a research company that doesn't work out doesn't make someone corrupt.
View on StockTwits ↗$ONCR I own 18000 shares on my swedish bank Avanza, and have'nt received any dividend. Anyone else in similar situation?
View on StockTwits ↗
$ONCR Congrats to folks who bought for less than 10 cents. You guys made good trade and profit. I sold 500k shares at 0.01 a couple of days back. Feeling very sad that I couldn’t hold till end of December. Anyway god should have other plans for me or that’s what my luck is
View on StockTwits ↗
$ONCR payout is $0.1393/sh. •Payment date December 29, 2023 •Record date December 27, 2023 •Ex-dividend date January 2, 2024
View on StockTwits ↗
$ONCR big whales covering ehile trading in retail cannot buy nor sell, its gamestock all over
View on StockTwits ↗$ONCR Too bad my swedish broker wont let me sell this, almost at break even...
View on StockTwits ↗@Miok Huh? Totally false. $ONCR has no employees, no products, no CEO, and no board. It's just an accounting firm overseeing the liquidation. $CCCC isn't the same at all.
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.